Announcement PDF RNS Number : 9665L BSF Enterprise PLC 17 December 2025 17th December 2025 BSF Enterprise PLC Result of General Meeting BSF Enterprise PLC (LSE:BSFA) (the "Company") a leading innovator in tissue engineered materials, is pleased to announce that at the Company's General Meeting held earlier today, all resolutions proposed were duly passed by shareholders by way of a poll, the results of which were as follows: Resolution Poll Results For Against Total Withheld 1 Shares 36,699,697 185,451 36,885,148 0 % 99.50% 0.50% 100% 0 2 Shares 36,757,931 127,217 36,885,148 0 % 99.66% 0.34% 100% 0 3 Shares 36,745,136 140,012 36,885,148 0 % 99.62% 0.38% 100% 0 4 Shares 36,749,586 127,207 36,876,793 8,355 % 99.66% 0.34% 100% n/a 5 Shares 36,740,626 144,522 36,885,148 0 % 99.61% 0.39% 100% 0 Engage with the BSF Enterprise management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor website here: https://bsfenterprise.com/link/rkD7AP For further enquiries, please visit www.bsfenterprise.com or contact: BSF Enterprise PLC Geoff Baker - Executive Director Che Connon - CEO & Director https://bsfenterprise.com/s/a1f22b Shard Capital (Broker) Damon Heath Isabella Pierre 0207 186 9000 0207 186 9927 ISIN of the Ordinary Shares is GB00BHNBDQ51. SEDOL Code is BHNBDQ5. Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43 About BSF Enterprise PLC BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab- grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ROMFFIFFWEISESE